Sort
21,281 grants matching “influenza”
Molecular Mechanisms for the High Pathogenicity of 1918 Influenza Virus
$602,426Yoshihiro Kawaoka · University Of Wisconsin-Madison · R01 · FY2013 · AI
Predictive fitness models for influenza vaccine strain selection
$602,331Marta Luksza · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AI
Predictive fitness models for influenza vaccine strain selection
$602,331Marta Luksza · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · AI
Analysis of Historical Influenza Viruses
$602,309Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Reverse Genetic Analysis of Antiviral Resistance Mechanisms
$602,263Shizuo Akira · Ut Southwestern Medical Center · P01 · FY2015 · AI
Reverse Genetic Analysis of Antiviral Resistance Mechanisms
$602,263Shizuo Akira · Ut Southwestern Medical Center · P01 · FY2016 · AI
Modulation of the Immune Response to Cutaneous Immunization by S. aureus
$602,249Raif Salim Geha · National Jewish Health · U19 · FY2015 · AI
miRNA Regulation of Vascular Permeability and Inflammation in the Lung Injury
$602,207Eva Nozik Grayck · University Of Colorado Denver · R01 · FY2015 · HL
Systems Immunology
$602,117John S Tsang · University Of Maryland Baltimore · U19 · FY2021 · AI
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)
$601,546Ann R Falsey · University Of Rochester · UM1 · FY2021 · AI
Dissecting the molecular mechanisms of lung injury during mechanical ventilation
$601,461Joshua A Englert · Ohio State University · R01 · FY2021 · HL
Virtual Patient Cohorts to Illuminate Immunologic Drivers of Influenza Severity
$601,440Amber M Smith · University Of Tennessee Health Sci Ctr · R01 · FY2023 · AI
Floss: a novel method for oral mucosal vaccination
$601,354Harvinder Singh Gill · North Carolina State University Raleigh · R01 · FY2024 · DE
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$601,278Richard Rothman · Johns Hopkins University · N01 · FY2017 · AI
Defining the Fc-correlates of protection against influenza
$601,251Galit Alter · Massachusetts General Hospital · R01 · FY2021 · AI
Defining the Fc-correlates of protection against influenza
$601,251Daniel Lingwood · Massachusetts General Hospital · R01 · FY2022 · AI
Defining the Fc-correlates of protection against influenza
$601,251Daniel Lingwood · Massachusetts General Hospital · R01 · FY2024 · AI
Defining the Fc-correlates of protection against influenza
$601,251Daniel Lingwood · Massachusetts General Hospital · R01 · FY2023 · AI
Predictive fitness models for influenza vaccine strain selection
$601,250Marta Luksza · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · AI
Influenza vaccine failure in adults over age 75: role of chronic CMV infection
$601,128Sean X Leng · Johns Hopkins University · R01 · FY2016 · AI
Arsenic and immune response to influenza vaccination in pregnant women and newborns
$600,834Christopher D Heaney · Johns Hopkins University · R01 · FY2021 · ES
Transgenerational exposures as modifiers of host defense against infection
$600,510B. Paige Lawrence · University Of Rochester · R01 · FY2013 · ES
Fusion: Vaccine conjugate technology to advance vaccine safety and efficacy
$600,477Kendal Ryter · University Of Montana · R01 · FY2022 · AI
Sustaining Surveillance Networks and Response to Seasonal and Pandemic Influenza
$600,452Jean-Michel Heraud · Pasteur Institute From Madagascar · U51 · FY2015 · IP
High-resolution single cell profiling of vaccine responsiveness in the elderly
$600,281Jacques F Banchereau · Jackson Laboratory · R01 · FY2019 · AI